83 related articles for article (PubMed ID: 27208462)
1. Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
Sanfilippo KM; Wang TF; Gage BF; Luo S; Riedell P; Carson KR
Thromb Res; 2016 Jul; 143():86-90. PubMed ID: 27208462
[TBL] [Abstract][Full Text] [Related]
2. Incidence of venous thromboembolism and predictive ability of age-adjusted international prognostic index for prediction of venous thromboembolism in Asian patients with diffuse large B-cell lymphoma.
Hantrakun N; Phinyo P; Tantiworawit A; Rattarittamrong E; Chai-Adisaksopha C; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Niprapan P; Norasetthada L
J Thromb Thrombolysis; 2024 Mar; 57(3):473-482. PubMed ID: 38091158
[TBL] [Abstract][Full Text] [Related]
3. Outdoor artificial light at night and risk of non-Hodgkin lymphoma among women in the California Teachers Study cohort.
Zhong C; Franklin M; Wiemels J; McKean-Cowdin R; Chung NT; Benbow J; Wang SS; Lacey JV; Longcore T
Cancer Epidemiol; 2020 Dec; 69():101811. PubMed ID: 33002844
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of and Risk Factors for Venous Thromboembolism in Patients With Lymphoma: A Meta-Analysis.
Jiang C; Liu T; Xu L; Lv J; Liu Y
Oncol Nurs Forum; 2023 Dec; 51(1):59-69. PubMed ID: 38108447
[TBL] [Abstract][Full Text] [Related]
5. The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients.
Abdel-Razeq H; Ma'koseh M; Abdel-Razeq R; Amarin R; Abufara A; Mansour R; Manasrah M; Al-Rwashdeh M; Bater R
Front Oncol; 2021; 11():677776. PubMed ID: 34123847
[TBL] [Abstract][Full Text] [Related]
6. PNT2258, a novel deoxyribonucleic acid inhibitor, induces cell cycle arrest and apoptosis via a distinct mechanism of action: a new class of drug for non-Hodgkin's lymphoma.
Ebrahim AS; Kandouz M; Liddane A; Sabbagh H; Hou Y; Li C; Al-Katib A
Oncotarget; 2016 Jul; 7(27):42374-42384. PubMed ID: 27283896
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment C-reactive protein was an independent prognostic factor for patients with diffuse large B-cell lymphoma treated with RCHOP.
Wang J; Zhou M; Wang X; Xu J; Chen B; Ouyang J
Clin Chim Acta; 2016 Aug; 459():150-154. PubMed ID: 27262822
[TBL] [Abstract][Full Text] [Related]
8. Ranking occupational contexts associated with risk of non-Hodgkin lymphoma.
Rieutort D; Moyne O; Cocco P; de Gaudemaris R; Bicout DJ
Am J Ind Med; 2016 Jul; 59(7):561-74. PubMed ID: 27214653
[TBL] [Abstract][Full Text] [Related]
9. Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma.
Borg IH; Bendtsen MD; Bøgsted M; Madsen J; Severinsen MT
Leuk Lymphoma; 2016 Dec; 57(12):2771-2776. PubMed ID: 27266904
[TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Cancer; 2019 Dec; 125(24):4498-4508. PubMed ID: 31469420
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism incidence in hematologic malignancies.
Kekre N; Connors JM
Blood Rev; 2019 Jan; 33():24-32. PubMed ID: 30262170
[TBL] [Abstract][Full Text] [Related]
12. Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Dogar O; Keding A; Gabe R; Marshall AM; Huque R; Barua D; Fatima R; Khan A; Zahid R; Mansoor S; Kotz D; Boeckmann M; Elsey H; Kralikova E; Parrott S; Li J; Readshaw A; Sheikh A; Siddiqi K;
Lancet Glob Health; 2020 Nov; 8(11):e1408-e1417. PubMed ID: 33069301
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment.
Antic D; Jelicic J; Vukovic V; Nikolovski S; Mihaljevic B
Blood Rev; 2018 Mar; 32(2):144-158. PubMed ID: 29126566
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated thrombosis in hematologic malignancies.
Fukatsu M; Ikezoe T
Int J Hematol; 2024 May; 119(5):516-525. PubMed ID: 38270784
[TBL] [Abstract][Full Text] [Related]
15. Zanubrutinib-lenalidomide-rituximab (ZR
Wang Y; Xu J; Li P; Xu Y; Xue H; Liu P
Ann Hematol; 2024 Feb; 103(2):499-510. PubMed ID: 37957370
[TBL] [Abstract][Full Text] [Related]
16. Map of thrombogenesis in viral infections and viral-driven tumours.
Neto BV; Tavares V; Santos JMO; Cerqueira F; Pereira D; Medeiros R
Discov Oncol; 2023 Jan; 14(1):3. PubMed ID: 36617364
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Venous Thrombosis of Lower Limbs after Cesarean Section Based on Smart Medical Air Pressure Therapy Instrument.
Yin Y; Xiao X; Peng L
Biomed Res Int; 2022; 2022():1451881. PubMed ID: 35941974
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and Predictors of Venous Thromboembolism Among Lymphoma Patients Undergoing Chemotherapy: A Cohort Study in China.
Chen Y; Lei H; Wang W; Zhu J; Zeng C; Lu Z; Li L; Li D; Long B; Liu H
Front Pharmacol; 2022; 13():901887. PubMed ID: 35677441
[No Abstract] [Full Text] [Related]
19. Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients.
Otasevic V; Mihaljevic B; Milic N; Stanisavljevic D; Vukovic V; Tomic K; Fareed J; Antic D
Thromb J; 2022 Apr; 20(1):20. PubMed ID: 35439998
[TBL] [Abstract][Full Text] [Related]
20. Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.
Gangaraju R; Davis ES; Bhatia S; Kenzik KM
Cancer; 2022 Jun; 128(12):2348-2357. PubMed ID: 35363373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
